Thruvision Group PLC Director Share Dealing-correction & further trade (6447K)
May 06 2022 - 7:12AM
UK Regulatory
TIDMTHRU
RNS Number : 6447K
Thruvision Group PLC
06 May 2022
6 May 2022
Thruvision Group plc
(" Thruvision " or the " Company ")
Director Share Dealing-correction and further trade
Thruvision (AIM:THRU), the leading provider of "safe distance"
people-screening technology to the international security market,
provides an update to the announcement made on 20 April 2022
regarding the share purchase by Katrina Nurse, a Non-Executive
Director of Thruvision, and her spouse, Mark Nurse, a Closely
Associated Person.
In that announcement, it was stated that 67,000 Thruvision
shares were purchased by each of Katrina Nurse and Mark Nurse at a
price of 29.9p per share. The price was incorrectly stated and
should have been reported as 32p per share.
In addition, Mark Nurse sold 9,591 Thruvision shares on 3 May
2022 at a price of 33.1p per share. This transaction was triggered
by an automatic process within the fund in which the shares are
held and was not intentional. Accordingly, Mark Nurse re-purchased
9,591 Thruvision shares on 4 May 2022 at a price of 33.5p per
share.
Following these transactions, the beneficial shareholding in the
Company of Katrina Nurse and her closely Associated Persons remains
unchanged at 134,000 Thruvision shares, representing 0.09% of the
Company's total issued share capital and total voting rights.
The notifications below, made in accordance with the
requirements of the Market Abuse Regulation, provides further
detail:
1. Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Mark Nurse, spouse of Katrina Nurse
----------------------------------------- ---------------------------------------
2. Reason for the notification
----------------------------------------------------------------------------------
(a) Position/status Closely Associated Person of Katrina
Nurse, a Non-Executive Director
----------------------------------------- ---------------------------------------
(b) Initial notification/ Initial notification
Amendment
----------------------------------------- ---------------------------------------
3. Details of the issuer
----------------------------------------------------------------------------------
(a) Name Thruvision Group plc
----------------------------------------- ---------------------------------------
(b) LEI 213800IZG9GM6G2TZE04
----------------------------------------- ---------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
(a) Description of the Ordinary shares of GBP0.01 each
Financial Instrument
----------------------------------------- ---------------------------------------
(b) Identification code GB00B627R876
of the Financial
Instrument
----------------------------------------- ---------------------------------------
(c) Nature of the transaction Sale of shares
----------------------------------------- ---------------------------------------
(d) Price(s) and volume(s) Price(s) Volume(s)
------------------ -------------------
33.1p 9,591
------------------ -------------------
(e) Aggregated information N/A
* Aggregated volume
- Price
----------------------------------------- ---------------------------------------
(f) Date of the transaction 3 May 2022
----------------------------------------- ---------------------------------------
(g) Place of the transaction London Stock Exchange
----------------------------------------- ---------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Mark Nurse, spouse of Katrina Nurse
----------------------------------------- ---------------------------------------
2. Reason for the notification
----------------------------------------------------------------------------------
(a) Position/status Closely Associated Person of Katrina
Nurse, a Non-Executive Director
----------------------------------------- ---------------------------------------
(b) Initial notification/ Initial notification
Amendment
----------------------------------------- ---------------------------------------
3. Details of the issuer
----------------------------------------------------------------------------------
(a) Name Thruvision Group plc
----------------------------------------- ---------------------------------------
(b) LEI 213800IZG9GM6G2TZE04
----------------------------------------- ---------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
(a) Description of the Ordinary shares of GBP0.01 each
Financial Instrument
----------------------------------------- ---------------------------------------
(b) Identification code GB00B627R876
of the Financial
Instrument
----------------------------------------- ---------------------------------------
(c) Nature of the transaction purchase of shares
----------------------------------------- ---------------------------------------
(d) Price(s) and volume(s) Price(s) Volume(s)
------------------ -------------------
33.5p 9,591
------------------ -------------------
(e) Aggregated information N/A
* Aggregated volume
- Price
----------------------------------------- ---------------------------------------
(f) Date of the transaction 4 May 2022
----------------------------------------- ---------------------------------------
(g) Place of the transaction London Stock Exchange
----------------------------------------- ---------------------------------------
For further information please contact:
Thruvision Group plc +44 (0)1235 425400
Tom Black, Executive Chairman
Colin Evans, Chief Executive
Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970
Patrick Robb / James Rudd / Sebastian Lawrence
FTI Consulting LLP +44 (0)20 3727 1000
Matt Dixon
Tom Blundell
About Thruvision
Addressing the urgent need for "safe distance" people security
screening in the COVID era, Thruvision is uniquely capable of
detecting metallic and non-metallic items including weapons,
explosives and contraband items that are hidden under clothing, at
distances between 3 and 10m. Using patented passive terahertz
technology, Thruvision completely removes the need for physical
"pat-downs" and has been vetted and approved by the US
Transportation Security Administration for surface transportation.
Operationally deployed in 20 countries around the world, Thruvision
is used for aviation security, retail supply chain loss prevention,
customs and border control, and public area security. The company
has offices near Oxford and Washington DC.
www.thruvision.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEAFSKEFEAEFA
(END) Dow Jones Newswires
May 06, 2022 07:12 ET (11:12 GMT)
Thruvision (LSE:THRU)
Historical Stock Chart
From Jul 2024 to Aug 2024
Thruvision (LSE:THRU)
Historical Stock Chart
From Aug 2023 to Aug 2024